LYMS:F:F-Lyxor UCITS Nasdaq-100 D-EUR (EUR)

ETF | Others |

Last Closing

USD 79.84

Change

0.00 (0.00)%

Market Cap

N/A

Volume

168.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-8.18 (-1.36%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.48 (+0.91%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-0.43 (-0.40%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.95 (+0.40%)

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

-0.09 (-1.20%)

USD 43.00B
0ZC:F Zscaler Inc

+2.84 (+1.54%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-2.42 (-1.79%)

USD 24.77B

ETFs Containing LYMS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.05% 13% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.05% 13% F 33% F
Trailing 12 Months  
Capital Gain 17.76% 77% C+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.76% 74% C 59% D-
Trailing 5 Years  
Capital Gain 158.55% 99% N/A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 158.55% 99% N/A 74% C
Average Annual (5 Year Horizon)  
Capital Gain 20.97% 94% A 81% B-
Dividend Return 20.97% 92% A 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.08% 20% F 65% D
Risk Adjusted Return 99.46% 90% A- 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.